Quantcast

AbbVie


Recent News About AbbVie View More

Trump DOJ punishes hedge fund manager who sued drug companies and shorted their stocks

By Daniel Fisher | Feb 7, 2019

The Trump Justice Department, following a tougher policy toward dubious False Claims Act lawsuits by private citizens, has moved to dismiss a pair of lawsuits by a former hedge-fund manager who shorted stock in pharmaceutical companies he accused of a wide-ranging price-fixing conspiracy.

AbbVie files appeal contesting landmark $448 million antitrust win for Federal Trade Commission

By Mary Ann Magnell | Aug 23, 2018

PHILADELPHIA (Legal Newsline) — Defendants AbbVie Inc., Abbott Laboratories and Unimed Pharmaceuticals LLC filed an appeal on Aug. 6 in a U.S. District Court in response to the final judgment in an antitrust case that found in favor of the Federal Trade Commission.

The Record Network